title: [Psoriasis induced by infliximab: a paradoxical event].
authors.forename: Marcos A
authors.initials: MA
authors.lastname: González-López
authors.forename: Ricardo
authors.initials: R
authors.lastname: Blanco-Alonso
authors.forename: Sonsoles
authors.initials: S
authors.lastname: Yáñez-Díaz
authors.forename: Héctor
authors.initials: H
authors.lastname: Fernández-Llaca
mesh_terms: D000328:Adult; D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D003424:Crohn Disease / Q000188:drug therapy; D005260:Female; D006801:Humans; D000069285:Infliximab; D011565:Psoriasis / Q000139:chemically induced*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab